Artelo Biosciences, Inc. Common Stock (ARTL)

Artelo Biosciences, Inc. is a biotechnology company focused on developing novel therapies that target the endocannabinoid system to treat various conditions, including cancer, pain, and inflammation. The company's approach involves identifying and advancing small-molecule drugs that modulate cannabinoid receptors and related pathways. Founded with an emphasis on innovative research, Artelo Biosciences aims to improve patient outcomes by leveraging the therapeutic potential of the endocannabinoid system.

🚫 Artelo Biosciences, Inc. Common Stock does not pay dividends

Company News

Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire Inc. • Delveinsight • July 10, 2025

The cannabinoid agonist market is gaining momentum with expanding medical cannabis legalization and growing clinical validation for treating chronic pain, epilepsy, and inflammatory conditions. Over 20 pharmaceutical companies are actively developing cannabinoid agonist drugs with promising pipeline candidates.

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga • Lisa Levin • September 7, 2023

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for alternatives to safes made by Liberty Safe. Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) jumped 86.1% to $8.45. Wheeler posted Series D redemption forms on its website. Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 68% to $0.3578 after the company announced to acquire NextTrip for around $48 million and sell assets of quality assurance software to strategic buyer. Rosecliff Acquisition Corp I (NASDAQ: RCLF) gained 48.4% to $15.34. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 26.5% to $0.1512 after declining 7% on Wednesday. Hitek Global Inc. (NASDAQ: HKIT) shares jumped 25% to $4.50 after falling 87% on Wednesday. Semantix, Inc. (NASDAQ: STIX) gained 20% to $1.39. Asensus Surgical, Inc. (NYSE: ASXC) surged 18.7% to $0.3443 after the company collaborated with NVIDIA for Asensus's Intelligent Surgical Unit. Designer Brands Inc. (NYSE: DBI) gained 16% to $12.06 after the company reported upbeat second-quarter results. G-III Apparel Group, Ltd. (NASDAQ: GIII) surged 13.7% to $21.95 after the company reported upbeat second-quarter results. InnSuites Hospitality Trust (NYSE: IHT) jumped 13.2% to $1.67. Calavo Growers, Inc. (NASDAQ: CVGW) gained 12.8% to $35.26 after the company reported third-quarter results. PARTS iD, Inc. (NYSE: ID) climbed 12.8% to $0.2650. InnSuites Hospitality Trust (NYSE: IHT) rose 12.5% to $1.66. DatChat, Inc. (NASDAQ: DATS) surged 12% to $0.5479. ATIF Holdings Limited (NASDAQ: ATIF) gained 12% to $1.45. Artelo Biosciences, Inc. (NASDAQ: ARTL) shares rose 8.5% to $2.55. Artelo Biosciences has completed a pre-IND (Investigational New Drug) meeting with the FDA regarding the development plan for ART26.12. Couchbase, Inc. (NASDAQ: BASE) climbed 5.9% to $17.47 following second-quarter results. WestRock Company (NYSE: WRK) gained 5.6% to $33.68 after the company said it is discussing ...

Artelo's (ARTL) FABP5 Inhibitor Effective in Pre-Clinical Study
Zacks Investment Research • Zacks Equity Research • August 17, 2022

Artelo Biosciences (ARTL) reports positive pre-clinical data from one of its FABP5 inhibitors in anxiety-related disorders. Stock up.

Best Penny Stocks To Buy Now? 7 Stocks Under $1 With Big News Today
PennyStocks • J. Samuel • April 13, 2022

Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy Now? 7 Stocks Under $1 With Big News Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.